The Board finds the veteran's period of service to be etiologically related to his acute myelogenous leukemia, and acute myelogenous leukemia to be the cause of the veteran's death.
The deciding factor: It was as likely as not that the hematologic evidence of pre-leukemia was present during the veteran's active military service or ACDUTRA period due to exposure to Agent Orange.
- Claimed conditions
- acute myelogenous leukemia
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- January 28, 2009
- Citation
- 0902897
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The appeal is remanded to the RO for further development and a determination on whether exposure to ionizing radiation in service caused or contributed to the Veteran's acute myelogenous leukemia.
- Remanded (sent back)
The Board remands the claim for a medical opinion addressing whether the Veteran's left eye condition is related to service, as it found that the condition did not preexist service.
- Granted
The Board granted service connection for prostate cancer, related to in-service exposures at Camp Lejeune.
- Granted
The Veteran is granted an effective date of August 10, 2022, for the grant of service connection for sinusitis based on the PACT Act.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.